Analysis of the Efficiency of Photothermal and Photodynamic Cancer Therapy via Nanogolds and Photosensitizers
- Authors
-
-
Jui-Teng Lin
New Vision Inc. 5F, No. 27, Lane 10, Datong Dist. Jiuquan St, Taipei, Taiwan
-
- Keywords:
- Â Lasers, optimal, modeling, heat diffusion, photochemical kinetics.
- Abstract
-
Factors influencing the cancer therapy efficiency in both photothermal therapy (PTT) and photodynamic therapy (PDT) using nanogold particles and photosensitizers, respectively, are analyzed. In PTT, heat diffusion kinetics is used to calculate the temperature increase resulted from the nanogold absorption of light energy, whereas photochemical kinetics is used to find the efficacy of PDT, or the generation rate of reactive oxygen species. The critical factors of the PTT/PDT synergistic efficacy include: the concentration of the initiator (nanogold or photosensitizers) in the treated medium, the wavelength and energy of the light applied to the medium. Optimal parameters are calculated for maximum PDT efficacy. In PTT, diode laser (at 810 nm) is used to heat nanogolds (rod-shape or core-shell). In PDT, photosensitizers of riboflavin, 5-ALA, methylene blue and indocyanine green may be used with the associate light at wavelength of (365, 430 nm), (530-670 nm) and (780-850 nm) respectively. Both single light or dual light in infrared or visible wavelength are proposed to activate the photosensitizers or nanogolds. Optimization is required for maximum synergistic efficacy.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 22-01-2017
- Issue
- Vol. 6 No. 1 (2017)
- Section
- Articles
How to Cite
Similar Articles
- Najia Mansoor, Rafeeq Alam Khan, Johannes Schueller, Dagmar Ettlinge, Philipp Buchner, Martin Czejka, Tasneem Ahmad, Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Indra Kanta Maitra, Sangita Bhattacharjee, Debnath Bhattacharyya, Tai-Hoon Kim, Samir Kumar Bandyopadhyay, Adaptive Edge Detection Technique Towards Features Extraction from Mammogram Images , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Amoura Abouelnaga, Ghada A. Mutawa, Hassan Abdelghaffar, Mohamed Sobh, Sahar Hamed, Shaker A. Mousa, Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve) , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Ananda M. Chakrabarty, COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr, Zhe-Sheng Chen, Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Zeli Huang, Jiezhan Feng, Shaoen Li, Weihong Wei, Guoyi Zhang, Qiuxia Lu, Yongfeng Wu, Li Lin, Tao Xu, Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma? , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine, Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- J.L. Layton, J.F. Renzulli II, A.M. Taber, D. Golijanin, J.E. Collins, H.H. Safran, A.E. Mega, Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Janet Wangari-Talbot, Elizabeth Hopper-Borge, Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Tatiana I. Bulycheva, Svetlana A. Mayakova, Simon V. Skurkovich , Disease-Free Remission Exceeding 37 Years in Patients Treated as Children for Acute Leukemia (AL) with Immunotherapy Using Viable (Cryopreserved) Allogeneic Leukemic Cells Pages 254-26 , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Jui-Teng Lin, Kuo-Ti Chen, Hsia-Wei Liu, Analysis of Kinetics and Efficacy of Anti-Cancer via Oxygen-Enhanced Photodynamic Therapy , Journal of Cancer Research Updates: Vol. 7 No. 1 (2018)